1 – 10 of 112
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2018
- A feasibility study on adaptive 18F-FDG-PET-guided radiotherapy for recurrent and second primary head and neck cancer in the previously irradiated territory
- Metastatic burden in newly diagnosed hormone-naive metastatic prostate cancer : comparing definitions of CHAARTED and LATITUDE trial
- 2017
- Preclinical data on the combination of cisplatin and anti-CD70 therapy in non-small cell lung cancer as an excellent match in the era of combination therapy
- A patient with acquired factor X deficiency and metastatic transitional cell carcinoma of the bladder : is there a link between metastasis and factor deficiency in solid tumors?
- Turning the tide : clinical utility of PD-L1 expression in squamous cell carcinoma of the head and neck
- Phase I dose-escalation study of the anti-CD70 antibody ARGX-110 in advanced malignancies
- A phase I global trial targeting multiple solid and hematologic malignancies through a NKG2D receptor-based CAR-T immunotherapy
- A phase I/II trial of fixed-dose stereotactic body radiotherapy with sequential or concurrent pembrolizumab in metastatic urothelial carcinoma : evaluation of safety and clinical and immunologic response
- Combined high dose radiation and pazopanib in metastatic renal cell carcinoma : a phase I dose escalation trial
- Metastatic burden in newly diagnosed hormone-naive metastatic prostate cancer : comparing the definitions of CHAARTED and LATITUDE trial